Name: Century Therapeutics, Inc. (IPSC) Financial Statements
Creator: FinSpry

Century Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Century Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	6.59	2.24	5.20	0.00	0.00
Cost of Revenue	107.24	92.71	97.17	75.65	0.00
Gross Profit	-100.66	2.24	5.20	-75.65	0.00
Operating Expenses
Research & Development	107.24	92.71	97.17	75.65	39.68
Selling, General & Administrative	34.51	34.71	31.86	19.24	9.50
Operating Expenses	34.51	148.78	129.03	94.88	49.18
Operating Income	-135.17	-146.55	-123.83	-94.88	-49.18
Other Income/Expense
Interest Income	13.01	12.68	4.42	0.38	0.70
Interest Expense	0.00	-0.54	1.20	0.97	-0.38
Other Income/Expense	0.35	0.38	-10.00	0.38	0.00
Income
Income Before Tax	-124.78	-134.79	-130.84	-95.78	-53.58
Income Tax Expense	1.79	1.88	0.09	0.04	0.00
Net Income	-126.57	-136.67	-130.93	-95.82	-53.58
Net Income - Continuous Operations	-126.57	-136.67	-130.93	-95.82	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-121.86	-121.11	-121.20	-91.06	-47.77
EBIT	-135.17	-134.25	-129.64	-94.81	-49.18
Depreciation & Amortization	13.30	13.04	8.44	3.75	1.40
Earnings Per Share
Basic EPS	-2.00	-2.00	-2.00	-3.00	-7.00
Diluted EPS	-2.00	-2.00	-2.00	-3.00	-7.00
Basic Shares Outstanding	78.65	59.31	57.76	32.39	7.48
Diluted Shares Outstanding	78.65	57.76	57.76	32.39	7.48